FIH Clinical Trial Planning for Radiopharmaceuticals: From IND to Patient Dosing, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into how to design and execute a first-in-human trial for a radiopharmaceutical agent. The featured speakers will discuss regulatory considerations across the US, EU and other global regions. The speakers will also share best practices for site readiness, radiation compliance and isotope logistics. Attendees will learn about operational strategies to accelerate timelines and reduce trial risk.

TORONTO, Nov. 18, 2025 /PRNewswire/ -- Launching a first-in-human (FIH) clinical trial for a radiopharmaceutical therapy (RLT) presents a unique set of challenges that extend well beyond those of a traditional oncology program. From coordinating protocol requirements concerning isotope availability to site selection, including radiation compliance and detailed planning for isotope logistics, sponsors must navigate a complex operational landscape to bring their therapy into clinical use successfully.

In this webinar, the featured speakers will explore the critical operational steps required to move a radiopharmaceutical candidate from IND submission to first patient dosing. Drawing on decades of hands-on experience, this webinar will break down the essential infrastructure, partnerships and strategic planning elements required to ensure a smooth FIH launch.

Topics will include global regulatory considerations (FDA, EMA and beyond), best practices for site readiness and staff training and how to manage the logistics of radioligand supply chains. Attendees will also gain insights into how companion imaging, dosimetry planning and patient access strategies can be integrated early to streamline development and reduce risk.

Whether preparing for an initial IND submission or anticipating clinical startup, this session will offer practical guidance and real-world examples designed to help RLT developers avoid common pitfalls, accelerate timelines and build a strong foundation for success.

Register for this webinar to learn how to operationalize a successful FIH clinical trial for radiopharmaceutical therapies.

Join experts including Jenny Keppler, MBA, Vice President, Translational Medicine from TD2 Oncology, for the live webinar on Wednesday, December 10, 2025, at 1pm EST (10am PST).

For more information, or to register for this event, visit FIH Clinical Trial Planning for Radiopharmaceuticals: From IND to Patient Dosing.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks